testbiotech

Bilder

US company runs into trouble over soy from New Genetic Engineering

Calyxt raised high expectations

29 September 2022 / Calyxt was the first company to bring seeds derived from New Genetic Engineering to the US market. In 2019, the company started selling seeds for growing a soybean that had been genetically engineered in its oil content with gene scissors, and was supposedly suitable for the production of particularly healthy food. However, the soybean failed to produce the desired yields for farmers, and in 2020 Calyxt exited this line of business due to unprofitability. Sales and the value of Calyxt stock fell dramatically as a result.

Canada: Genetically engineered oilseed rape crosses out into wild species

Glyphosate-resistant weed on the rise

21 September 2022 / In Canada, cross-pollination of genetically engineered oilseed rape into a related weed species has occurred, and the weed is now spreading in the fields. This was revealed in a recent study by Canadian scientists. The spread of the plants challenges previous assumptions about their safety.

The CRISPR/Cas ‘gene scissors’ birthday

Ten years ago a crucial scientific paper paved the way for New Genetic Engineering

9 August 2022 / On 17 August, ten years ago, a crucial scientific paper officially published, for the first time described how CRISPR/Cas9 can be used to induce targeted genetic changes in the genome. It is a process which uses an RNA molecule as a ‘tracer’ to guide the gene scissors to a specific site in the genome where they are activated. The enzyme Cas9 vital to this process was originally found in bacteria and belongs to the category of nucleases which have the potential to cut the double strands of DNA.

Prospective technology assessment essential for New GE in agriculture

EU Commission heavily criticised for one-sided approach

19 July 2022 / Testbiotech is demanding that applications of New GE (new genomic techniques, NGTs) in agriculture should undergo a comprehensive prospective technology assessment. The demand is being made against the backdrop of a public consultation organised by the EU Commission on the future regulation of genetically engineered plants. Testbiotech is warning that the Commission is aiming to lower standards in the approval processes to an extent which is equivalent to deregulation.